arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Tempest Therapeutics, Inc.

TPST

$0.92 0.00 (+0.54%) at close

15 Visible periods

26 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Tempest Therapeutics, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $3.8M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -314.9% ↘

FCF / Share $-6.46 ↘

Trailing P/E —

Price / Book 0.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$653.00K

↑ +135.7% —

Net Income Profit after all expenses

$-26.26M

↑ +37.2% —

FCF / Share Free cash flow per share

$-6.46

↓ -438.9% —

Long-Term Debt Long-term obligations

$6.40M

↓ -39.0% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -314.9% is weak on an absolute basis (target > 10%)
Interest CoverageInterest Coverage of -138.41x is weak on an absolute basis (target > 5x)

Health Breakdown

Financial Health ↓

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

FY 2014

FY 2015

FY 2016

FY 2017

$0.00

FY 2018

$0.00

FY 2019

FY 2020

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	135.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1597%)	—	—	—	—	—
EPS Growth YoY (%)	-322.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	21.5% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	38.2% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	58.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	81.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	37.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-41.9% Weak ↓ Weak Declining Year-over-year change in net income	17.4% Good ↑ Good Improving Year-over-year change in net income	-26.2% Weak ↓ Weak Declining Year-over-year change in net income	-47.3% Weak ↓ Weak Declining Year-over-year change in net income	56.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-63.9% Weak ↓ Weak Declining Year-over-year change in net income	67.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-2.8% Weak ↑ Weak Improving Year-over-year change in net income	-12.3% Weak ↑ Weak Improving Year-over-year change in net income	-47.9% Weak ↑ Weak Improving Year-over-year change in net income	-70.5% Weak Weak Year-over-year change in net income	-115.0% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-438.9% Weak ↓ Weak Declining Year-over-year change in free cash flow	32.8% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	34.8% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	60.2% Excellent Excellent Year-over-year change in free cash flow	83.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
FCF / Net Income (x)	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.24x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	-314.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-130.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-61.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-96.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	22.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-61.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	51.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-75.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-56.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-86.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-55.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-34.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-157.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-101.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-56.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-75.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-84.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-60.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-425.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-66.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-51.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-73.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-61.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-41.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	-218.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1559%)	-110.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-834%)	-197.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1414%)	-78.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-622%)	27.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+86%)	-76.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-607%)	-38.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-356%)	64.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+331%)	-76.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-607%)	-57.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-485%)	-89.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-697%)	-69.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-564%)	-44.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-393%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Debt to Equity (x)	—	0.33x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-44%)	0.39x Good ↓ Good Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-35%)	0.57x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	0.42x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-30%)	—	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	-0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-101%)	—	—	—	—	—	—
Interest Coverage (x)	-138.41x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-35.71x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-20.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-21.41x Weak Weak Operating income divided by interest expense Optimal: > 5x	-21.05x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-200.55x Weak Weak Operating income divided by interest expense Optimal: > 5x	-292.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—
Net Debt (USD)	$-7.71M	$-23.87M	$-28.73M	$-20.83M	$-36.76M	$-18.82M	$-62.31M	$-72.90M	$-16.98M	$-43.93M	$-43.22M	$-6.41M	$-18.08M	$-14.78M	$-4.54M
Debt / EBITDA (x)	—	-0.15x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.36x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.31x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.57x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.01x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.01x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Basic EPS, GAAP (USD)	$-6.33	$-1.50	$-1.91	$-3.09	$-7.47	$-41.03	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-6.46	$-1.20	$-1.79	$-2.74	$-6.88	$-40.73	—	—	—	—	—	—	—	—	—
Dividend per Share (USD)	—	—	—	—	—	—	$0.00	$0.00	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.35	$0.43	$1.21	$1.72	$5.23	$-146.94	$3.21	$5.31	$-530.53	$3.04	$4.65	$2.30	$2.38	$2.43	$-1.96
Tangible Book Value per Share (USD)	$1.35	$0.43	$1.21	$1.72	$5.23	$-146.94	$3.21	$5.31	$-530.53	$3.04	$4.65	$2.30	$2.38	$2.43	$-1.96
Basic Weighted Avg Shares (shares)	4.15M	27.90M	15.42M	11.55M	3.79M	468,161	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$4.96M	$17.25M	$30.95M	$25.67M	$48.94M	$16.60M	$58.61M	$73.61M	$15.65M	$103.23M	$118.62M	$51.70M	$39.30M	$29.88M	$3.91M
LT Debt (USD)	—	$6.40M	$10.50M	$10.40M	$15.07M	—	$168.00K	$383.00K	$599.00K	—	—	—	—	—	—
Total Equity (USD)	$6.67M	$19.13M	$26.77M	$18.11M	$36.12M	$-68.79M	$58.55M	$70.95M	$-130.69M	$108.22M	$126.85M	$55.33M	$41.70M	$30.72M	$-2.38M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	$653.00K	$277.00K	$0.00	—	—	—
Depreciation Expense (USD)	$266.00K	$389.00K	$381.00K	$638.00K	$374.00K	$339.00K	$97.00K	$32.00K	$28.00K	$2.24M	$1.29M	$450.00K	$231.00K	$93.00K	—
Net Income, GAAP (USD)	$-26.26M	$-41.84M	$-29.49M	$-35.71M	$-28.30M	$-19.21M	$-44.57M	$-27.19M	$-84.58M	$-82.26M	$-73.22M	$-49.52M	$-29.04M	$-13.51M	—
Operating Cash Flow (USD)	$-26.82M	$-33.03M	$-27.36M	$-31.07M	$-25.96M	$-19.02M	$-41.22M	$-23.65M	$-20.34M	$-61.73M	$-50.29M	$-30.59M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 62 quarters

Tempest Therapeutics, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare TPST with peers